检索

期
标题
作者
编号 2 (2023)
Treatment for diffuse benign breast diseases
Kravchenko E., Naboka M.
PDF
(Rus)
编号 3 (2024)
Treatment for cyclic mastodynia in patients with benign breast diseases
Kravchenko E., Naboka M., Sosnin M., Tsygankova M.
PDF
(Rus)
编号 4 (2017)
Correction of mastalgia and hyperprolactinaemia in women in perimenopause
Lazareva G.
PDF
(Rus)
编号 10 (2016)
MASTOPATHY: PATHOGENESIS AND A POSSIBILITY OF CORRECTION
Musina E., Kogan I.
PDF
(Rus)
编号 2 (2017)
Experience with indole-3-carbinol used to treat diseases of the breast and to prevent breast cancer
Smetnik A., Smetnik V., Kiselev V.
PDF
(Rus)
编号 10 (2020)
Use of vitamin D to maintain women’s reproductive health: realities and prospects
Maltseva L., Garifullova Y., Yupatov E.
PDF
(Rus)
编号 12 (2016)
EFFICACY OF MICRONIZED PROGESTERONE-CONTAINING TRANSDERMAL GEL IN THE TREATMENT OF FIBROCYSTIC MASTOPATHY: RESULTS OF A RUSSIAN STUDY
Andreeva E., Rozhkova N.
PDF
(Rus)
编号 12 (2021)
The breast and sex hormones
Smetnik A., Rodionov V., Kometova V., Burmenskaya O., Dardyk M., Sencha A., Ermakova E., Ashrafyan L.
PDF
(Rus)
编号 11 (2016)
TREATMENT FOR MASTALGIA IN THE PRESENCE OF DIFFUSE MASTOPATHY IN FEMALE PATIENTS DURING THE MENOPAUSAL TRANSITION PERIOD
Kulagina N.
PDF
(Rus)
编号 8 (2020)
Changes in the clinical symptoms of fibrocystic mastopathy during monotherapy with transdermal micronized progesterone: results of the BREAST-2 multicenter open prospective cohort study
Protasova A.
PDF
(Rus)
编号 11 (2014)
Treatment of mastalgia and mastodynia in peri-and postmenopause
Khanafiev G.
PDF
(Rus)
编号 5 (2020)
ESTROGEN-DEPENDENT CONDITIONS OF THE FEMALE REPRODUCTIVE SYSTEM: POSSIBILITIES OF NONHORMONAL THERAPY USING INDOLE-3-CARBINOL
KHASHUKOEVA A., KHLYNOVA S., ILYINA I., KERCHELAEVA S.
PDF
(Rus)
编号 7 (2013)
INDOLE CARBINOL IS A MULTITARGETED THERAPY OPTION FOR CYCLIC MASTODYNIA
KISELEV V., SMETNIK V., SUTURINA L., SELIVANOV S., RUDAKOVA E., RAKHMATULLINA I., ANDREYEVA E., FADEYEVA N., KHASANOV R., KULAGINA N., ROZHKOVA N., ARTYMUK N., GAVISOVA A., MUIZHNEK E., KUZNETSOV I., DRUKH V.
PDF
(Rus)
编号 9 (2018)
Clinical and pharmacological analysis of most commonly used drugs for the pharmacotherapy of fibrocystic breast disease
Shikh E., Makhova A., Smetnik A.
PDF
(Rus)
编号 8-1 (2012)
THE TIME COURSE OF CHANGES IN THE CLINICAL SYMPTOMS OF ANTIOXIDANDT DEFICIENCY AND ITS CORRECTION WITH THE HERBAL AGENT MASTODYNON IN WOMEN WITH DIFFUSE MASTOPATHY (BENIGN BREAST DISEASE)
SUTURINA L., POPOVA L.
PDF
(Rus)
编号 11 (2018)
Dynamics of clinical symptoms of fibrocystic breast disease in the course of the transdermal gel of micronized progesterone monotherapy: results of the Russian multicenter observational study BREAST
Protasova A., Andreyeva E., Rozhkova N., Vandeyeva E.
PDF
(Rus)
编号 2 (2012)
TOPICAL USE OF MICRONIZED PROGESTERONE IN REPRODUCTIVE-AGE PATIENTS WITH MASTOPATHY
KOGAN I., MUSINA E.
PDF
(Rus)
1 - 17 的 17 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
  • 使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
  • 使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如： "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语
##common.cookie##